DOCSLIB.ORG

Vol. 42, No. 4, October 2015

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

JMRI J OURNAL OF M AGNETIC R ESONANCE I MAGING CME Article 855 Clinical Applications of Dual-Channel Transmit MRI: A Review Wyger M. Brink, Vikas Gulani, and Andrew G. Webb Review Articles 870 Congenital Heart Disease Assessment With 4D Flow MRI Shreyas S. Vasanawala, Kate Hanneman, Marcus T. Alley, and Albert Hsiao 887 Motion Artifacts in MRI: A Complex Problem With Many Partial Solutions Maxim Zaitsev, Julian Maclaren, and Michael Herbst Original Research Breast 902 Computational Approach to Radiogenomics of Breast Cancer: Luminal A and Luminal B Molecular Subtypes Are Associated With Imaging Features on Routine Breast MRI Extracted Using Computer Vision Algorithms Lars J. Grimm, Jing Zhang, and Maciej A. Mazurowski 908 Gradient Nonlinearity Correction to Improve Apparent Diffusion Coefficient Accuracy and Standardization in the American College of Radiology Imaging Network 6698 Breast Cancer Trial David C. Newitt, Ek T. Tan, Lisa J. Wilmes, Thomas L. Chenevert, John Kornak, Luca Marinelli, and Nola Hylton 920 MRI Phenotype of Breast Cancer: Kinetic Assessment for Molecular Subtypes Eric Blaschke and Hiroyuki Abe Head and Neck 925 Acceleration of MRI of the Vocal Tract Provides Additional Insight Into Articulator Modifications Michael Burdumy, Louisa Traser, Bernhard Richter, Matthias Echternach, Jan G. Korvink, Jurgen€ Hennig, and Maxim Zaitsev 936 Dynamic Contrast-Enhanced MRI Evaluates the Early Response of Human Head and Neck Tumor Xenografts Following Anti-EMMPRIN Therapy With Cisplatin or Irradiation Hyunki Kim, Yolanda E. Hartman, Guihua Zhai, Thomas K. Chung, Melissa L. Korb, Timothy M. Beasley, Tong Zhou, and Eben L. Rosenthal Cardiac 946 Patient Adaptive Maximal Resolution Magnetic Resonance Myocardial Stress Perfusion Imaging David P. Ripley, Adam K. McDiarmid, Ananth Kidambi, Akhlaque Uddin, Peter P. Swoboda, Tarique A. Musa, Bara Erhayiem, Gavin J. Bainbridge, John P. Greenwood, Sven Plein, and David M. Higgins 954 Thoracic Aorta 3D Hemodynamics in Pediatric and Young Adult Patients With Bicuspid Aortic Valve Bradley D. Allen, Pim van Ooij, Alex J. Barker, Maria Carr, Maya Gabbour, Susanne Schnell, Kelly B. Jarvis, James C. Carr, Michael Markl, Cynthia Rigsby, and Joshua D. Robinson Technical Development Cardiac 964 Comparison of Image-Based and Reconstruction-Based Respiratory Motion Correction for Golden Radial Phase Encoding Coronary MR Angiography Nadia K. Paschke, Olaf Dossel,€ Tobias Schaeffter, Claudia Prieto, and Christoph Kolbitsch 972 Efficient Method for Analyzing MR Real-Time Cines: Toward Accurate Quantification of Left Ventricular Function Yin Wu, Ke Jiang, Na Zhang, Yinzhu Gao, Yucheng Chen, Hairong Zheng, Xin Liu, and Yiu-Cho Chung Original Research Abdomen 981 Immediate Post-Doxorubicin Drug-Eluting Beads Chemoembolization MR Apparent Diffusion Coefficient Quantification Predicts Response in Unresectable Hepatocellular Carcinoma: A Pilot Study Nima Kokabi, Juan C. Camacho, Minzhi Xing, Faramarz Edalat, Pardeep K. Mittal, and Hyun S. Kim VOLUME 42, NUMBER 4, OCTOBER 2015 990 Diffusion-Weighted MRI Does Not Reflect Kidney Fibrosis in a Rat Model of Fibrosis Peter Boor, Michael Perkuhn, Martin Weibrecht, Stephanie Zok, Ina V. Martin, Jurgen€ Gieseke, Felix Schoth, Tammo Ostendorf, Christiane Kuhl, and Jurgen€ Floege 999 Fast Imaging Strategies for Mouse Kidney Perfusion Measurement With Pseudocontinuous Arterial Spin Labeling (pCASL) at Ultra High Magnetic Field (11.75 Tesla) Valentin H. Prevost, Olivier M. Girard, Virginie Callot, Patrick J. Cozzone Pr, and Guillaume Duhamel 1009 Impaired Regulation of Portal Venous Flow in Response to a Meal Challenge as Quantified by 4D Flow MRI Alejandro Roldan-Alzate, Alex Frydrychowicz, Adnan Said, Kevin M. Johnson, Christopher J. Francois, Oliver Wieben, and Scott B. Reeder Musculoskeletal 1018 Assessment of Whole Spine Vertebral Bone Marrow Fat Using Chemical Shift-Encoding Based Water-Fat MRI Thomas Baum, Samuel P. Yap, Michael Dieckmeyer, Stefan Ruschke, Holger Eggers, Hendrik Kooijman, Ernst J. Rummeny, Jan S. Bauer, and Dimitrios C. Karampinos 1024 Beyond the Alpha Angle: Alternative Measurements for Quantifying Cam-type Deformities in Femoroacetabular Impingement Christine Ehrmann, Andrea B. Rosskopf, Christian W.A. Pfirrmann, and Reto Sutter 1032 Use of Quantitative MRI for the Detection of Progressive Cartilage Degeneration in a Mini-pig Model of Osteoarthritis Caused by Anterior Cruciate Ligament Transection Bo Wei, Min Zong, Chao Yan, Fengyong Mao, Yang Guo, Qingqiang Yao, Yan Xu, and Liming Wang 1039 Differentiating Benign From Malignant Vertebral Fractures Using T1-Weighted Dynamic Contrast-Enhanced MRI Julio Arevalo-Perez, Kyung K. Peck, John K. Lyo, Andrei I. Holodny, Eric Lis, and Sasan Karimi 1048 Multiparametric Analysis of Bone Marrow in Cancer Patients Using Simultaneous PET/MR Imaging: Correlation of Fat Fraction, Diffusivity, Metabolic Activity, and Anthropometric Data Christina Schraml, Marinus Schmid, Sergios Gatidis, Holger Schmidt, Christian la Fougere, Konstantin Nikolaou, and Nina F. Schwenzer 1057 Glycosaminoglycan Chemical Exchange Saturation Transfer of Lumbar Intervertebral Discs in Patients With Spondyloarthritis Christoph Schleich, Anja Muller-Lutz,€ Felix Matuschke, Philipp Sewerin, Ruben Sengewein, Benjamin Schmitt, Benedikt Ostendorf, Hans-Jorg€ Wittsack, Karolin Stanke, Gerald Antoch, and Falk Miese 1064 Off-Resonance Saturation Ratio Obtained With Ultrashort Echo Time-Magnetization Transfer Techniques Is Sensitive to Changes in Static Tensile Loading of Tendons and Degeneration Eric Y. Chang, Jiang Du, Reni Biswas, Sheronda Statum, Chantal Pauli, Won C. Bae, and Christine B. Chung Pelvis 1072 Minimization of Errors in Biexponential T2 Measurements of the Prostate Nima Gilani, Andrew B. Rosenkrantz, Paul Malcolm, and Glyn Johnson 1078 Comparison of Stretched-Exponential and Monoexponential Model Diffusion-Weighted Imaging in Prostate Cancer and Normal Tissues Xiaohang Liu, Liangping Zhou, Weijun Peng, He Wang, and Yong Zhang 1086 TE 5 32 ms vs TE 5 100 ms Echo-Time 1H-Magnetic Resonance Spectroscopy in Prostate Cancer: Tumor Metabolite Depiction and Absolute Concentrations in Tumors and Adjacent Tissues Meer Basharat, Geoffrey S. Payne, Veronica A. Morgan, Chris Parker, David Dearnaley, and Nandita M. deSouza 1094 Diagnostic Accuracy of Diffusion-Weighted MRI for Differentiation of Cervical Cancer and Benign Cervical Lesions at 3.0T: Comparison With Routine MRI and Dynamic Contrast-Enhanced MRI Fei Kuang, Zhiping Yan, Huili Li, and Hao Feng Physics 1100 Experimental System to Detect a Labeled Cell Monolayer in a Microfluidic Environment Nicolas Gargam, Luc Darrasse, Jean-Sebastien Raynaud, Jean-Christoph Ginefri, Philippe Robert, and Marie Poirier-Quinot Neuroimaging 1106 TestÀRetest Reliability of Diffusion Measures in Cerebral White Matter: A Multiband Diffusion MRI Study Fei Duan, Tengda Zhao, Yong He, and Ni Shu 1117 MR Evaluation of Vessel Size Imaging of Human Gliomas: Validation by Histopathology Elias Kellner, Tobias Breyer, Peter Gall, Klaus Muller,€ Michael Trippel, Ori Staszewski, Florian Stein, Olaf Saborowski, Olga Dyakova, Horst Urbach, Valerij G Kiselev, and Irina Mader 1126 Optimization of Phase-Contrast MRI for the Quantification of Whole-Brain Cerebral Blood Flow Shin-Lei Peng, Pan Su, Fu-Nien Wang, Yan Cao, Rong Zhang, Hanzhang Lu, and Peiying Liu 1134 Longitudinal Three-Dimensional-T2WI-SPACE Study on Wallerian Degeneration in Cat Corticospinal Tract and Underlying Pathology Changes Min Zhang, Wen Qin, Yueshan Piao, Deyu Guo, Zixin Zhu, Xin Tian, Kuncheng Li, and Chunshui Yu 1144 TestÀRetest Reliability of Cerebral Blood Flow and Blood Oxygenation Level-Dependent Responses to Hypercapnia and Hyperoxia Using Dual-Echo Pseudo-Continuous Arterial Spin Labeling and Step Changes in the Fractional Composition of Inspired Gases Felipe B. Tancredi, Isabelle Lajoie, and Richard D. Hoge Technical Development Neuroimaging 1158 MRI Measurements of Intracranial Pressure in the Upright Posture: The Effect of the Hydrostatic Pressure Gradient Noam Alperin, Sang H. Lee, and Ahmet M. Bagci Volume 42, Number 4 was mailed the week of September 21, 2015.
Recommended publications
  • Features of MRI Stromal Enhancement with Neoadjuvant Chemotherapy: a Subgroup Analysis of the ACRIN 6657/I-SPY TRIAL

    Features of MRI Stromal Enhancement with Neoadjuvant Chemotherapy: a Subgroup Analysis of the ACRIN 6657/I-SPY TRIAL

    Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL Adam Olshen Denise Wolf Ella F. Jones David Newitt Laura van ‘t Veer Christina Yau Laura Esserman Julia D. Wulfkuhle Rosa I. Gallagher Lisa Singer Emanuel F. Petricoin, III Nola Hylton Catherine C. Park Adam Olshen, Denise Wolf, Ella F. Jones, David Newitt, Laura van ‘t Veer, Christina Yau, Laura Esserman, Julia D. Wulfkuhle, Rosa I. Gallagher, Lisa Singer, Emanuel F. Petricoin, , IIINola Hylton, Catherine C. Park, “Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL,” J. Med. Imag. 5(1), 011014 (2017), doi: 10.1117/1.JMI.5.1.011014. Downloaded From: https://www.spiedigitallibrary.org/journals/Journal-of-Medical-Imaging on 3/15/2018 Terms of Use: https://www.spiedigitallibrary.org/terms-of-use Journal of Medical Imaging 5(1), 011014 (Jan–Mar 2018) Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL Adam Olshen,a,b Denise Wolf,c Ella F. Jones,d David Newitt,e Laura van ‘t Veer,c Christina Yau,e Laura Esserman,e Julia D. Wulfkuhle,f Rosa I. Gallagher,f Lisa Singer,g Emanuel F. Petricoin III,f Nola Hylton,d and Catherine C. Parkb,g,* aUniversity of California San Francisco, Department of Biostatistics and Epidemiology, San Francisco, California, United States bUniversity of California San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States cUniversity
  • PROTOCOL—CONTACT Phone: (401) 863-9183 ACRIN PROTOCOL DEVELOPMENT Fax: (401) 863-9182 and REGULATORY COMPLIANCE Gatsonis@Stat.Brown.Edu for a COMPLETE PROTOCOL

    PROTOCOL—CONTACT Phone: (401) 863-9183 ACRIN PROTOCOL DEVELOPMENT Fax: (401) 863-9182 and REGULATORY COMPLIANCE [email protected] for a COMPLETE PROTOCOL

    AMERICAN COLLEGE OF RADIOLOGY IMAGING NETWORK ACRIN 6657 CONTRAST-ENHANCED BREAST MRI and MRS FOR EVALUATION OF PATIENTS UNDERGOING NEOADJUVANT TREATMENT FOR LOCALLY ADVANCED BREAST CANCER ACRIN Principal Investigator InterSPORE Principal Investigator Nola M. Hylton, PhD Laura J. Esserman, MD, MBA University of California, San Francisco UCSF Mt. Zion MRSC, Box 1290 Carol Franc Buck Breast Ctr. One Irving St., Room AC-109 2356 Sutter St., 6th Floor San Francisco, CA 94143-1290 San Francisco, CA 94115 Phone: (415) 476-8856 Phone: (415) 885-7691 Fax: (415) 475-8809 Fax: (415) 353-9571 [email protected] [email protected] Statistician Constantine Gatsonis, PhD Center for Statistical Sciences Brown University, Box G-S121-7 121 South Main Street, 7th Floor Providence, RI 02912 PARTIAL PROTOCOL—CONTACT Phone: (401) 863-9183 ACRIN PROTOCOL DEVELOPMENT Fax: (401) 863-9182 AND REGULATORY COMPLIANCE [email protected] FOR A COMPLETE PROTOCOL Radiology Co-Investigators and Institutions Etta Pisano, MD Paul Weatherall, MD University of North Carolina-Chapel Hill University of Texas, Southwestern Mitchell Schnall, MD, PhD, Mark Rosen, MD, PhD Constance Lehman, MD, PhD Hospital of the University of Pennsylvania University of Washington Sandra Polin, MD Robert Schmidt, MD,Gillean Newstead, MD Georgetown University University of Chicago Elizabeth Morris, MD Pat Bolan, Ph.D., Michael Garwood, Ph.D. Memorial Sloan Kettering Cancer Center University of Minnesota Wanda Bernreuter, MD University of Alabama Version Date: March 8,
  • Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy

    Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy

    cancers Review Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy Ella F. Jones 1,* , Deep K. Hathi 1, Rita Freimanis 1 , Rita A. Mukhtar 2, A. Jo Chien 3, Laura J. Esserman 4, Laura J. van’t Veer 3, Bonnie N. Joe 1 and Nola M. Hylton 1 1 Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94115, USA; [email protected] (D.K.H.); [email protected] (R.F.); [email protected] (B.N.J.); [email protected] (N.M.H.) 2 Department of Surgery, University of California, San Francisco, CA 94115, USA; [email protected] 3 School of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA; [email protected] (A.J.C.); [email protected] (L.J.v.V.) 4 Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA; [email protected] * Correspondence: [email protected] Received: 19 May 2020; Accepted: 5 June 2020; Published: 9 June 2020 Abstract: In recent years, neoadjuvant treatment trials have shown that breast cancer subtypes identified on the basis of genomic and/or molecular signatures exhibit different response rates and recurrence outcomes, with the implication that subtype-specific treatment approaches are needed. Estrogen receptor-positive (ER+) breast cancers present a unique set of challenges for determining optimal neoadjuvant treatment approaches. There is increased recognition that not all ER+ breast cancers benefit from chemotherapy, and that there may be a subset of ER+ breast cancers that can be treated effectively using endocrine therapies alone.
  • 1.Title Page

    1.Title Page

    .', '•Cpmpm$9-n of Tlsstie BifBtaioA "•'; E%h-pmluti&xi- aad iSlMd^/pili^siQ^^Psp^ Imagmg In ;: •• Fatlapts • wit a Leeal|y: ;AdA:adavF: B? past: Gaasay la M :V:::l'i11EAl:S:^l-':.';:; SiPpEtpd ;m paMs J satisfadtipa dClMaAspFJtany^ :of. MAST BE &£ ;8g}ffiGGE EkmGtl pal; I PGgldg la If a GIEAldsIAf E B1¥IA1CM: ii DEDICATION I dedicate this thesis to my family for nursing me with affections and love & the living memories of my grandparents. ACKNOWLEDGMENTS I am grateful to my advisor Dr. Nola Hylton for her invaluable guidance and constant encouragement. I express sincere gratitude to Dr. Ella Jones without whose support and suggestions this work would have been difficult. I would like to thank Dr. Lisa Wilmes for many engaging and interesting discussions. I specially thank Rebekah Mclaughlin for assisting my thesis writing enormously. I thank David Newitt and Evelyn Proctor who assisted a lot in this study. iii Comparison of Tissue Diffusion Measurements Using High-resolution and Standard Diffusion Tensor Imaging in Patients with Locally Advanced Breast Cancer Cheng-Liang Liu1 1UCSF Masters of Science in Biomedical Imaging Program, San Francisco, California ABSTRACT Objective: To evaluate fractional anisotropy (FA) in comparison to apparent diffusion coefficient (ADC) for discriminating between cancer and normal breast tissue using standard and high resolution diffusion tensor imaging (DTI). Materials and Methods: Dynamic contrast enhanced MRI, standard DTI, and high- resolution DTI data were collected in ten patients with locally advanced breast cancer before the start of neoadjuvant treatment. Regions of interest were selected in tumor and ipsilateral normal tissue.
  • ADC As an Early Indiahor of Response to Neoadjuvant Therapy

    ADC As an Early Indiahor of Response to Neoadjuvant Therapy

    ADC as an early indiaHor of response to neoadjuvant therapy I HhSfh Utbmtued in partial satisfaction of the revustrenseitis lbs' the deexee of MASTER OF SCIENCE RADUATE DIVISION UNIVERSITY OF CALIFORNIA, SAN FRANCISCO ! ii Acknowledgement I would like to thank my advisor Dr. Nola Hylton and Dr. Ella Jones, for exposing me to the field of Breast MR and for their guidance and direction both professionally and personally. I would like to thank Jessica Gibbs, whose attention to detail and constant optimism was indispensable. Thank you to Dr. David Newitt, for being generous with his time and helping me work through IDL issues. I am grateful to Dr. Wen Li and Dr. Lisa Wilmes, for sharing their knowledge and expertise with me, and for many engaging intellectual conversations. I would like to thank Dr. Roland Krug, Dr. Alastair Martin, and Dr. Viola Rieke for their guidance and time as members of my thesis committee. Lastly I would like to thank my family and friends for their support as I completed this work. ! iii ADC as an early indicator of breast cancer response to neoadjuvant treatment Elizabeth Li Abstract Quantitative MRI can accelerate drug development by providing non-invasive methods to determine treatment response. The primary aim of this study is to assess the change in normalized apparent diffusion coefficient values (ΔADCN), derived from diffusion- weighted MRI (DWI), as an alternative method to standard dynamic contrast-enhanced (DCE) MRI for assessing response of primary breast tumors to neoadjuvant chemotherapy. Secondary aims are to: assess the influence of image quality scoring on the predictive performance of ΔADCN; test correlations between ΔADCN and change in functional tumor volume (ΔFTV) at early (ΔFTV2) and late (ΔFTV4) time points; and assess ΔADCN of responders versus non-responders.
  • 11Th Annual RADIOLOGY IMAGING RESEARCH SYMPOSIUM October 21, 2014

    11Th Annual RADIOLOGY IMAGING RESEARCH SYMPOSIUM October 21, 2014

    UCSF Department of Radiology and Biomedical Imaging 11th Annual RADIOLOGY IMAGING RESEARCH SYMPOSIUM October 21, 2014 Organizers: Peder Larson, PhD, Jing Liu, PhD, Katherine Murphy, and Brad Nakano Acknowledgements: Michael Evans, PhD, K. Pallav Kolli, MD, Roland Krug, PhD, Xiaojuan Li, PhD, Sharmila Majumdar, PhD Susanne Mueller, PhD, Andrew Phelps, MD, Elissa Price, MD, Viola Rieke, PhD, David Saloner, PhD Vivek Swarnakar, Duygu Tosun-Turgut, PhD, Khai Vu, MD, Esther Yuh, MD, PhD, Xiaoliang Zhang, PhD Research Interest Groups Research Interest Groups (RIGs) bring together departmental PhD and MD research and clinical faculty, as well as trainees across our campuses into synergized research groups. They provide a structure for PhD faculty akin to Clinical Sections for purposes of improving departmental visibility and connection. Each group is typically led by a PhD Director and MD Co-Director, who collectively (with their SRG colleagues) form an Executive Research Council. Body RIG: John Kurhanewicz, PhD (Director) Z. Jane Wang, MD (Co-Director) Brain RIG: Sarah J. Nelson, PhD (Director) Srikantan Nagarajan, PhD (Co-Director) Pratik Mukherjee, MD, PhD (Co-Director) Breast Cancer RIG: Nola Hylton, PhD (Director) Bonnie N. Joe, MD, PhD (Co-Director) Cardiovascular RIG: David Saloner, PhD (Director) Karen Ordovas, MD (Co-Director) Musculoskeletal RIG: Sharmila Majumdar, PhD (Director) Thomas Link, MD, PhD (Co-Director) Neurodegenerative RIG: Pratik Mukherjee MD, PhD (Co-Director) Norbert Schuff, PhD (Co-Director) Pediatrics/Fetal RIG: A. James Barkovich, MD (Director) Specialized Resource Groups Specialized Resource Groups (SRGs) bring together departmental PhD and MD research and clinical faculty, who do technique development. Each group is typically led by either a PhD or MD Director, who collectively (with their RIG colleagues) form an Executive Research Council.
  • Height, Adiposity and Body Fat Distribution and Breast Density in Young Women

    Height, Adiposity and Body Fat Distribution and Breast Density in Young Women

    University of Massachusetts Medical School eScholarship@UMMS Open Access Articles Open Access Publications by UMMS Authors 2012-07-16 Height, adiposity and body fat distribution and breast density in young women Joanne F. Dorgan Fox Chase Cancer Center Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/oapubs Part of the Life Sciences Commons, and the Neoplasms Commons Repository Citation Dorgan JF, Klifa C, Shepherd JA, Egleston BL, Kwiterovich PO, Himes JH, Gabriel KP, Van Horn L, Snetselaar LG, Stevens VJ, Barton BA, Robson AM, Lasser NL, Deshmukh S, Hylton NM. (2012). Height, adiposity and body fat distribution and breast density in young women. Open Access Articles. https://doi.org/10.1186/bcr3228. Retrieved from https://escholarship.umassmed.edu/oapubs/2313 This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. Breast Cancer Research This Provisional PDF corresponds to the article as it appeared upon acceptance. Copyedited and fully formatted PDF and full text (HTML) versions will be made available soon. Height, adiposity and body fat distribution and breast density in young women Breast Cancer Research 2012, 14:R107 doi:10.1186/bcr3228 Joanne F Dorgan ([email protected]) Catherine Klifa ([email protected]) John A Shepherd ([email protected]) Brian L Egleston
  • Diffusion MRI Methods for Improved Treatment Monitoring in Breast Cancer by Sheye Oluwaseun Aliu a Dissertation Submitted In

    Diffusion MRI Methods for Improved Treatment Monitoring in Breast Cancer by Sheye Oluwaseun Aliu a Dissertation Submitted In

    Diffusion MRI Methods for Improved Treatment Monitoring in Breast Cancer by Sheye Oluwaseun Aliu A dissertation submitted in partial satisfaction of the requirements for the degree of Joint Doctor of Philosophy with the University of California, San Francisco in Bioengineering in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Nola M. Hylton, Chair Professor Steven M. Conolly Professor Marian C. Diamond Fall 2009 Diffusion MRI Methods for Improved Treatment Monitoring in Breast Cancer © 2009 by Sheye Oluwaseun Aliu Abstract Diffusion MRI Methods for Improved Treatment Monitoring in Breast Cancer by Sheye Oluwaseun Aliu Joint Doctor of Philosophy in Bioengineering with the University of California, San Francisco University of California, Berkeley Professor Nola M. Hylton, Chair As of the time of this writing, the gold standard for monitoring primary breast tumor response to chemotherapy treatment is clinical examination based on palpable changes in tumor size. This method is non–quantitative, highly subjective and generally imposes that treatment is completed before efficacy can be assessed, defeating the purpose of monitoring and eliminating the prospect of adaptive treatment. MRI methods including tissue enhancement kinetics are increasingly used to provide improved monitoring of treatment response in breast and other cancers. In this work, I investigate the added value of diffusion weighted imaging, an MRI technique, for treatment monitoring in breast cancer. This investigation was first conducted in a thoroughly characterized animal model of breast cancer and subsequently in breast cancer patients. I furthered this work by exploring the potential benefit of diffusion tensor imaging, an MRI technique relatively novel to breast imaging, for breast cancer treatment monitoring.
  • ISMRM Workshop on Breast MRI: Advancing the State of The

    ISMRM Workshop on Breast MRI: Advancing the State of The

    BRIDGING THE GAP BETWEEN CLINICAL NEEDS AND TECHNOLOGICAL SOLUTIONS ISMRM COMMUNITY FOR CLINICIANS International Society for Magnetic Resonance in Medicine www.ismrm.org AND SCIENTISTS ISMRM WORKSHOP SERIES 2018 GROUNDBREAKING MR SCIENCE • SUPERIOR MR EDUCATION • GLOBAL NETWORKING ISMRM Workshop on Breast MRI: Advancing the State of the Art In Affiliation with the Society of Breast Imaging (SBI) & European Society of Breast Imaging (EUSOBI) Las Vegas, NV, USA • 10–13 September 2018 TARGET AUDIENCE: This workshop is targeted towards basic scientists and physicians using MR in breast disease diagnosis and research; clinicians (oncologists, radiologists, pathologists, surgeons, radiation oncologists); and Ph.D. students or residents starting in the field of breast imaging. COMMITTEE CHAIR Elizabeth Morris, M.D., F.A.C.R. Memorial Sloan-Kettering Cancer Center OVERVIEW EDUCATIONAL OBJECTIVES New York, NY, USA This workshop aims to gather technical and Upon completion of this activity, participants COMMITTEE clinical experts in the field of MRI in breast cancer should be able to: diagnosis and management. The advantages and Kristine Glunde, Ph.D. • Describe the standard clinical shortcomings of the current techniques used in Johns Hopkins University implementation and uses for breast MRI; Baltimore, MD, USA breast MRI will be discussed, as well as new and • Recognize possible pitfalls associated Ileana Hancu, Ph.D. emerging approaches in the era of precision GE Global Research Center medicine, such as radiomics, radiogenomics, with the use of MRI in breast disease Niskayuna, NY, USA and big data. Other topics of discussion include management; Thomas Helbich, M.D. correlation of MR imaging findings to epi-/ genomic, • List the factors that can impact image University of Vienna proteomic, transcriptomic and metabolomic quality in breast MRI and list solutions that Vienna, Austria information, and quantitative biomarkers for breast can mitigate such problems; Nola Hylton, Ph.D.
  • Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging (DOSI)

    Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging (DOSI)

    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Cancer Manuscript Author Res. Author manuscript; Manuscript Author available in PMC 2017 October 15. Published in final edited form as: Cancer Res. 2016 October 15; 76(20): 5933–5944. doi:10.1158/0008-5472.CAN-16-0346. Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging (DOSI) Bruce J. Tromberg1,*, Zheng Zhang2, Anaïs Leproux1, Thomas D. O’Sullivan1, Albert E. Cerussi1, Philip Carpenter3, Rita S. Mehta4, Darren Roblyer5, Wei Yang6, Keith D. Paulsen7, Brian W. Pogue7, Shudong Jiang7, Peter Kaufman8, Arjun G. Yodh AG9, So Hyun Chung9, Mitchell Schnall10, Bradley S. Snyder11, Nola Hylton12, David A. Boas13, Stefan A. Carp13, Steven J. Isakoff14, and David Mankoff15 on behalf of the ACRIN 6691 investigators Bruce J. Tromberg: [email protected]; Zheng Zhang: [email protected]; Anaïs Leproux: [email protected]; Thomas D. O’Sullivan: [email protected]; Albert E. Cerussi: [email protected]; Philip Carpenter: [email protected]; Rita S. Mehta: [email protected]; Darren Roblyer: [email protected]; Wei Yang: [email protected]; Keith D. Paulsen: [email protected]; Brian W. Pogue: [email protected]; Shudong Jiang: [email protected]; Peter Kaufman: [email protected]; Arjun G. Yodh AG: [email protected]; So Hyun Chung: [email protected]; Mitchell Schnall: [email protected]; Bradley S. Snyder: [email protected]; Nola Hylton: [email protected]; David A. Boas: [email protected]; Stefan A. Carp: [email protected]; Steven J.
  • Onsite Program | 1 Welcome to the 2019 SBI/ACR Breast Imaging Symposium

    Onsite Program | 1 Welcome to the 2019 SBI/ACR Breast Imaging Symposium

    Connect to the Mobile App NOTE TAKING & BOOKMARKING Annotate directly on presentation slides and bookmark specific slides to view at a later time. CREATE & SHARE SCHEDULES Attendees can schedule sessions and personal items, then sync with their own calendars! PERSONAL SUMMARY Notes and bookmarked slides can be viewed, exported as PDFs, or printed at any time. SOCIAL FEATURES Attendees can view and communicate with other app users, speakers, and exhibitors. 1. Download the SBI Meetings App • Search for “SBI Meetings” in the Apple App Store or Google Play Store. • INSTALL and OPEN the app then SELECT the event: “2019 SBI/ACR Breast Imaging Symposium” • CLICK the icon to launch your app. 2. Login to your event App To start using your event app, select “Create Account” and type your name and email address. If you already have an account, select “Login” and enter your username (your email) and password. 3. Take notes on presentation slides Find the presentation you need and interact with the presentation by drawing on slides or highlighting text. Use the note-taking mode to type your notes next to each slide. Access your notes and print them out by clicking the “My Notes” on the home screen or “Online Personal Summary” in the hamburger menu. No mobile device? No Problem. As long as you have an internet connection, you can take notes on presentations through your laptop via this link: http://bit.ly/SBIACR19 Welcome to the 2019 SBI/ACR Breast Imaging Symposium Welcome to the 2019 SBI/ACR Breast Imaging At the conclusion Symposium, the largest breast imaging conference in of the symposium, the world! This conference is designed to bring together attendees should be the best speakers presenting the most up-to-date able to: information about the most important breast imaging topics.
  • Acknowledgements Learning Objectives

    Acknowledgements Learning Objectives

    Acknowledgements Radiology • Scott Graham Breast Cancer Advocates • Nola Hylton • Chloee Wendorf • Susie Brain • Dian Heditsian • Bonnie Joe • Michael White • MRI and PET Imaging Markers For Kim Ray • Jim Slater Funding Support • Deep Hathi • Salma Javin • Mt. Zion Health Fund Prediction of Treatment Response in • Margarita Watkins • Henry VanBrocklin • Breast Oncology Program • Wen Li Breast Care Center • Breast Cancer Patients • David Newitt Give Breast Cancer a Boot • Laura Esserman • Youngho Seo • Susan G. Komen SAC110017 Ella F. Jones, PhD • Rita Mukhtar • Ben Franc • NIH/NCI U01CA151235 [email protected] • Jo Chien • Rob Flavell • NIH/NCI P01CA210961 • Ruby Gao 4/20/2021 • Miguel Pampaloni • NIH/NCI R01CA227763 • Julissa Melina‐Vega • Courtney Lawhn‐Heath • DOD W81XWH‐18‐1‐0671 Breast cancer patients and their families 4/20/2021 2 Learning objectives Neoadjuvant chemotherapy (NAC) in breast cancer National Surgical Adjuvant Breast and Bowel Project (NSABP): protocol B‐18 and B‐27 . How imaging markers are used in the neoadjuvant treatment trial . No difference in disease‐free survival or overall survival in patients . MRI markers for the prediction to treatment response and recurrence receiving neoadjuvant chemotherapy with AC or AC + taxane compared to free survival those receiving adjuvant therapy . Use of PET molecular imaging markers to inform assess early treatment . Opportunities Clinical Trial Model response and drug selection • Assess the intact primary tumor and refine treatment • Understand tumor biology in responseAdjuvant to treatment Neoadjuvant • DevelopEndpoint new tools for prognosticSurvival assessment Primary tumor • Accelerate new drug development response Timeline Years (5‐20) Months Rastogi et al., JCO, 2008 3 4 1 4/20/2021 [ADD PRESENTATION TITLE: INSERT TAB > HEADER & FOOTER > NOTES AND HANDOUTS] Contrast‐enhanced MR Imaging I‐SPY 1/ACRIN 6657 PI: Esserman and Hylton Pre‐contrast (t ) t Functional tumor volume 0 1 t2 .